China's central bank reported that by April 2026, the daily average trading volume on the Shanghai and Shenzhen stock exchanges reached 2.34 trillion yuan, a 1.3% increase from the previous month. The Shanghai Composite Index rose 5.7% to 4112.2 points, while the Shenzhen Component Index surged 12.1% to 15107.6 points. Separately, Lifang Pharmaceutical received approval from the National Medical Products Administration for its amlodipine potassium tablets, indicated for treating adult primary hypertension. AI
Summary written by gemini-2.5-flash-lite from 1 source. How we write summaries →
RANK_REASON This is a digest-style news item with multiple unrelated sections, none of which represent a significant standalone event.